{"database": "lobbying", "table": "lobbying_activities", "rows": [[1077344, "738fa514-c5ae-4bb0-984a-049b2c789679", "Q1", "CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.", 8511, "ONYX PHARMACEUTICALS", 2011, "first_quarter", "MED", "Innovation in biotechnology; biosimilars; patient access to treatments; FDA accelerated approval process; orphan drugs for \nrare diseases.", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2011-04-15T14:28:54.157000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1077344"], "units": {}, "query_ms": 0.5239199963398278, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}